Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Amgen's (AMGN) Blincyto Gets FDA Nod for Consolidation Treatment
10:55am, Monday, 17'th Jun 2024
Amgen's (AMGN) Blincyto is now approved for the treatment of adult and pediatric patients one month and older with Philadelphia chromosome-negative B-ALL in the consolidation phase, regardless of MRD
Top Dow Jones Stocks To Buy Today? 2 To Know
10:09am, Monday, 17'th Jun 2024
Dow Jones stocks to watch in the stock market this week.
BLINCYTO ® Added to Multiphase Consolidation Chemotherapy Reduced Risk of Death by 58% Showing Superior Overall Survival Versus Chemotherapy Alone First and Only Bispecific T-cell Engager (BiTE �
A.I. Impact On Biopharma: LLY, AMGN, TMO, CRL
01:27pm, Friday, 14'th Jun 2024
The use of artificial intelligence across biopharma and life science tools and services is developing quickly. Will A.I. become a major disruptive technology in healthcare with the potential to signif
3 Stocks to Buy as Ozempic Surges in Popularity
06:15am, Thursday, 13'th Jun 2024
Ozempic and Wegovy (semaglutide for diabetes and weight loss, respectively) are popular weight-loss drugs that have taken the world by storm. Indeed, the craze is showing no signs of slowing down as m
AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024
09:00am, Wednesday, 12'th Jun 2024
Data Highlight Positive Outcomes in Uncontrolled Gout With KRYSTEXXA ® and Progress in Addressing Sjögren's Disease THOUSAND OAKS, Calif. , June 12, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today a
Amgen Inc. (AMGN) Goldman Sachs 45th Annual Global Healthcare Conference Transcript
11:48am, Monday, 10'th Jun 2024
Amgen Inc. (NASDAQ:AMGN ) Goldman Sachs 45th Annual Global Healthcare Conference June 10, 2024 9:20 AM ET Company Participants James E. Bradner – EVP of Research and Development & Chief Scientific O
Why Amgen (AMGN) Dipped More Than Broader Market Today
06:57pm, Friday, 07'th Jun 2024
Amgen (AMGN) closed the most recent trading day at $305.02, moving -0.22% from the previous trading session.
Is Trending Stock Amgen Inc. (AMGN) a Buy Now?
10:00am, Friday, 07'th Jun 2024
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
A Simple $1 Million Passive Income Portfolio For Retirement
07:05am, Friday, 07'th Jun 2024
Warren Buffett once opined on how to live off of dividends in retirement. We discuss a simple way to follow his advice on this. We also share how to further enhance the yield on this portfolio while s
Amgen's (AMGN) Uplizna Meets Study Goal for Rare Disease
01:01pm, Thursday, 06'th Jun 2024
Data from a late-stage study shows that treatment with Amgen's (AMGN) Uplizna achieves a statistically significant reduction in the risk of flares in patients with IgG4-RD, a rare disease.
AMGEN TO PRESENT AT GOLDMAN SACHS 45TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
04:00pm, Wednesday, 05'th Jun 2024
THOUSAND OAKS, Calif. , June 5, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 45th Annual Global Healthcare Conference at 9:20 a.m.
Buy 1 June Dow Dog, And Watch 3
10:27am, Wednesday, 05'th Jun 2024
"The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors
Amgen's drug meets main goal in late-stage study for rare disease
09:45am, Wednesday, 05'th Jun 2024
Amgen said on Wednesday its drug to treat patients with an immune system-related condition has met the main goal of a late-stage study.
Data Show a Statistically Significant 87% Reduction in IgG4-RD Flares, With Primary and All Key Secondary Endpoints Met First Randomized, Placebo-Controlled Trial to Demonstrate Benefit in IgG4-RD THO
